Pregnancy Outcomes in Women with Long-Duration Type 1 Diabetes—25 Years of Experience
Open Access
- 8 October 2020
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (10), 3223
- https://doi.org/10.3390/jcm9103223
Abstract
Aims: Our study aimed to examine the pregnancy outcomes (maternal and fetal) concerning different models of antenatal care across a period of over 25 years (1993–2018) in 459 women with type 1 diabetes. Data from patients with a history of the condition lasting at least 15 years were considered eligible for analysis. Methods: The study group was divided into three cohorts based on the different models of treatment used in Poznan University Hospital, Poland: 1993–2000 (cohort I, n = 91), 2001–2005 (cohort II, n = 83), 2006–2018 (cohort III, n = 284). To identify predictors for the selected dichotomous outcomes, we calculated the risks for fetal or maternal complications as dependent variables for cohorts II and III against cohort I, using multivariate logistic regression analysis. Results: The mean gestational age was 36.8 ± 2.4 weeks in the total cohort. The percentages of deliveries before the 33rd and the 37th weeks was high. We observed a decreasing percentage during the following periods, from 41.5% in the first period to 30.4% in the third group. There was a tendency for newborn weight to show a gradual increase across three time periods (2850, 3189, 3321 g, p < 0.0001). In the last period, we noticed significantly more newborns delivered after 36 weeks with a weight above 4000 g and below 2500 g. Caesarean section was performed in 88% of patients from the whole group, but in the subsequent periods this number visibly decreased (from 97.6%, 86.7%, to 71%, p = 0.001). The number of emergency caesarean sections was lowest in the third period (27.5%, 16.7%, 11.2%, p = 0.006). We observed a decreasing number of “small for gestational age” newborns (SGA) in consecutive periods of treatment (from 24.4% to 8.7%, p = 0.002), but also a higher percentage of “large for gestational age” (LGA) newborns (from 6.1% to 21.6%, p = 0.001). Modification of treatment might be associated with the gradual reduction of SGA rates (cohort I 3.6%, cohort III 2.3% p < 0.0005). Conclusions: Strict glycemic and blood pressure control from the very beginning of pregnancy, as well as modern fetal surveillance techniques, may contribute to the improvement of perinatal outcomes in women with long-duration type 1 diabetes.Keywords
This publication has 33 references indexed in Scilit:
- Pregnancy Outcome Following Exposure to Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor AntagonistsHypertension, 2012
- Modern-Day Clinical Course of Type 1 Diabetes Mellitus After 30 Years' DurationArchives of Internal Medicine, 2009
- Vascular dysfunction in the diabetic placenta: causes and consequencesJournal of Anatomy, 2009
- Peri-Conceptional A1C and Risk of Serious Adverse Pregnancy Outcome in 933 Women With Type 1 DiabetesDiabetes Care, 2009
- Improved Pregnancy Outcome in Type 1 Diabetic Women With Microalbuminuria or Diabetic NephropathyDiabetes Care, 2009
- Reduced prevalence of early preterm delivery in women with Type 1 diabetes and microalbuminuria—possible effect of early antihypertensive treatment during pregnancyDiabetic Medicine, 2006
- Fetal weight and progression of diabetic retinopathyPublished by Wolters Kluwer Health ,2001
- Pregnancy Performance and Outcomes Associated with Diabetic NephropathyAmerican Journal of Perinatology, 1998
- Glycosylated Hemoglobin in Insulin-Dependent Diabetes Mellitus Related to PreeclampsiaAmerican Journal of Perinatology, 1998
- Effect of Pregnancy on Progression of Diabetic RetinopathyDiabetes Care, 1990